Deutsche Bank
NERV icon

Deutsche Bank’s Minerva Neurosciences NERV Stock Holding History

Deutsche Bank’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
+33,277
New +$180K ﹤0.01% 3299
2026
Q1 		– Sell
-1,500
Closed -$6.03K – 3699
2025
Q4 		$6.03K Buy
+1,500
New +$5.57K ﹤0.01% 3560
2021
Q3 		– Sell
-14,315
Closed -$266K – 4581
2021
Q2 		$266K Buy
14,315
+2,035
+17% +$43.8K ﹤0.01% 3620
2021
Q1 		$287K Buy
12,280
+6,788
+124% +$170K ﹤0.01% 3437
2020
Q4 		$103K Sell
5,492
-2,779
-34% -$70K ﹤0.01% 3835
2020
Q3 		$211K Buy
8,271
+6,244
+308% +$169K ﹤0.01% 3186
2020
Q2 		$58K Sell
2,027
-18,068
-90% -$1.06M ﹤0.01% 3738
2020
Q1 		$967K Buy
20,095
+18,778
+1,426% +$1.13M ﹤0.01% 2106
2019
Q4 		$74K Buy
1,317
+296
+29% +$13.1K ﹤0.01% 3736
2019
Q3 		$62K Sell
1,021
-1,640
-62% -$92.9K ﹤0.01% 3815
2019
Q2 		$119K Sell
2,661
-1,801
-40% -$90.1K ﹤0.01% 4120
2019
Q1 		$278K Sell
4,462
-2,026
-31% -$122K ﹤0.01% 3805
2018
Q4 		$349K Sell
6,488
-2,901
-31% -$212K ﹤0.01% 3554
2018
Q3 		$942K Buy
9,389
+533
+6% +$40.1K ﹤0.01% 3373
2018
Q2 		$585K Buy
8,856
+3,734
+73% +$227K ﹤0.01% 3762
2018
Q1 		$255K Sell
5,122
-3,437
-40% -$165K ﹤0.01% 4069
2017
Q4 		$413K Sell
8,559
-815
-9% -$40.4K ﹤0.01% 3707
2017
Q3 		$568K Buy
9,374
+5,399
+136% +$310K ﹤0.01% 3360
2017
Q2 		$280K Buy
3,975
+1,011
+34% +$65.4K ﹤0.01% 3753
2017
Q1 		$191K Buy
2,964
+1,489
+101% +$116K ﹤0.01% 3618
2016
Q4 		$138K Buy
1,475
+1,077
+271% +$110K ﹤0.01% 3899
2016
Q3 		$44K Buy
398
+85
+27% +$8.25K ﹤0.01% 4260
2016
Q2 		$24K Sell
313
-956
-75% -$60.8K ﹤0.01% 4703
2016
Q1 		$62K Buy
+1,269
New +$54.2K ﹤0.01% 4243
2015
Q3 		– Sell
-25
Closed -$1K – 5287
2015
Q2 		$1K Buy
+25
New +$1.07K ﹤0.01% 5276

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's NERV Position: Q2 2026 in Review

Deutsche Bank opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 33,277 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #3299 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in NERV as recently as Q4 2025.

Deutsche Bank first reported a position in NERV in Q2 2015 and has held it in 25 quarters since. The position peaked at $967K in Q1 2020. 61 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Deutsche Bank held 33,277 shares of Minerva Neurosciences worth $185K as of Q2 2026.
  • Minerva Neurosciences was a new Deutsche Bank position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3299 holding.
  • Deutsche Bank first reported a position in Minerva Neurosciences in Q2 2015 and has held it in 25 quarters since.
  • Deutsche Bank's Minerva Neurosciences position peaked at $967K in Q1 2020.
  • 61 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.